CLOV - NASDAQ
Clover Health Investments, Corp.
$3.96
+8.6%Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
At a Glance
Live Snapshotclov
Total Current Assets
Last Annual Value
307.86M
3-Year CAGR
-21%
5-Year CAGR
10%
10-Year CAGR
15%
Clover Health Investments, Corp. Competitors Analysis of Total Current Assets
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Clover Health Investments, Corp. NASDAQ:CLOV | 307.86M | -10.4% | -16.4% | N/A | |
 Twist Bioscience Corporation NASDAQ:TWST | 332.97M | -7.8% | -9.4% | 18.9% | |
 Certara, Inc. NASDAQ:CERT | 315.12M | -2.5% | 2.8% | N/A | |
 QuidelOrtho Corporation NASDAQ:QDEL | 1.45B | 3.4% | 0.1% | 20.4% | |
 Guardian Pharmacy Services, Inc. NYSE:GRDN | 221.63M | 19.6% | 14.7% | N/A | |
 PROCEPT BioRobotics Corporation NASDAQ:PRCT | 450.38M | 8.7% | 6.7% | N/A | |
 LifeStance Health Group, Inc. NASDAQ:LFST | 416.20M | 22.6% | 9.3% | N/A | |
 10x Genomics, Inc. NASDAQ:TXG | 684.45M | 4.7% | -1.7% | N/A | |
 Structure Therapeutics Inc. NASDAQ:GPCR | 1.57B | 49.1% | 70.4% | N/A | |
 National HealthCare Corporation AMEX:NHC | 448.18M | 3.3% | 1.0% | 4.4% |
Clover Health Investments, Corp. Fair Value Envelope
Related Guides
Continue your CLOV research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.